Non-Small Cell Lung Cancer

N/A

Published by: @Point of Care
Downloads
Revenue

Description

@Point of Care™ With @sk Cognitive is a clinical decision-making mobile platform. Non-Small Cell Lung Cancer @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care.
With @sk Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Watson, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care.
Non-Small Cell Lung Cancer @Point of Care™ is designed to:
• Support discovery and practice change
• Provide relevant, evidence-based disease-specific medical content
• Improve patient outcomes at the point of care
Features:
• Continually updated Non-Small Cell Lung Cancer content
• Topics in diagnosis, treatment, and care management developed with expert physician authors
• Case studies, videos, and interviews
• Access to actionable patient-recorded data
• Detailed reference list with access to original sources
• Continuing medical education credit (CME/CE)
• Surveys and peer polling
• Patient education resources to share with patients
• BreakingMED™ news feed
Hide Show More...

Screenshots

Non-Small Cell Lung Cancer FAQ

  • Is Non-Small Cell Lung Cancer free?

    Yes, Non-Small Cell Lung Cancer is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is Non-Small Cell Lung Cancer legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does Non-Small Cell Lung Cancer cost?

    Non-Small Cell Lung Cancer is free.

  • What is Non-Small Cell Lung Cancer revenue?

    To get estimated revenue of Non-Small Cell Lung Cancer app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in United Arab Emirates yet.
Ratings History

Non-Small Cell Lung Cancer Reviews

X

tsjbrmcrblgngtb on

United States

Very helpful. Thanks.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

Non-Small Cell Lung Cancer Competitors

Name
Respiratory COPD Exacerbation
BAP-65 and DECAF Score
GOLD Criteria for COPD
Assess Stages of COPD
ATS Journals App
Manual of Clinical Oncology
with Expert Recommentations
Cancer Pharmacology Manual
Anticancer Oncology Drug Guide
ChemoSafe
Assessing chemotherapy safety
Neuro-Oncology Trials App
Neuro-oncology: WTD
What's the data?
Non-Small-Cell Lung Cancer
Esophageal Cancer Stage

Non-Small Cell Lung Cancer Installs

Last 30 days

Non-Small Cell Lung Cancer Revenue

Last 30 days

Non-Small Cell Lung Cancer Revenue and Downloads

Gain valuable insights into Non-Small Cell Lung Cancer performance with our analytics.
Sign up now to access downloads, revenue, and more.